Abstract
Acinetobacter baumannii is a major human pathogen associated with multidrug-resistant nosocomial infections; its virulence is attributed to quorum-sensing-mediated biofilm formation, and disruption of biofilm formation is an attractive antivirulence strategy. Here, we report the first successful demonstration of biofilm disruption in a clinical isolate of A. baumannii S1, using a quorum-quenching lactonase obtained by directed evolution; this engineered lactonase significantly reduced the biomass of A. baumannii-associated biofilms, demonstrating the utility of this antivirulence strategy. Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Chow, J. Y., Yang, Y., Tay, S. B., Chua, K. L., & Yew, W. S. (2014). Disruption of biofilm formation by the human pathogen Acinetobacter baumannii using engineered quorum-quenching lactonases. Antimicrobial Agents and Chemotherapy, 58(3), 1802–1805. https://doi.org/10.1128/AAC.02410-13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.